Medical Device Sterilization Methods Explained
How do you choose the right medical device sterilization method? In this episode of MedDevice by Design, Ariana and Mark walk through FDA-approved options and explain how to select the right one for your product. From metals to plastics and electronics, not all devices can handle the same process.
Choosing the Right Method
The most common method is steam sterilization using an autoclave. This works well for metal tools like scalpels and orthopedic instruments. However, high heat can damage plastics, so it’s not always the best option.
For heat-sensitive components, ethylene oxide (ETO) is often used. It works at low temperatures, but requires long turnaround times and has safety concerns due to its carcinogenic nature.
Alternatives to ETO
Because of the risks with ETO, many facilities are moving to vaporized hydrogen peroxide plasma. It’s safer for staff and just as effective for sterilizing low-temperature devices. The FDA is also encouraging this transition.
Radiation is another solution. Gamma and E-beam sterilization are fast and effective, but typically only available at large, centralized facilities due to safety requirements.
What About Electronics?
Electronics present a special challenge. They often can’t handle heat or moisture. Designers must plan ahead, choosing components and layouts that limit the number of parts needing sterilization. Sometimes, only patient-contacting elements are sterilized.
If no standard option works, novel sterilization methods are allowed—but require thorough validation. You must prove the method is both effective and repeatable.
Understanding medical device sterilization helps ensure safety, performance, and compliance. Selecting the right method early can save time and cost in development.
Enjoying MedDevice by Design? Sign up to get new episodes sent to your inbox.
Related Resources
Ariana and Mark walk through what separates a clinical prototype from a proof-of-concept build, what determines how much testing and documentation you actually need, and where the regulatory line between significant risk and non-significant risk falls.
In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.
Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.
Nigel Syrotuck breaks down the realistic medical device V&V cost and schedule for terminally sterilized devices, picking up after design freeze and walking through each major phase of the process.